Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Cellectar Biosciences, Inc. (CLRB) had Current Ratio of 1.90 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.65M |
|
-- |
|
-- |
|
$5.79M |
|
$-5.79M |
|
$0.14M |
|
$-5.65M |
|
$-5.73M |
|
$-5.65M |
|
$-5.65M |
|
$-5.65M |
|
$-5.73M |
|
$-5.79M |
|
$-5.90M |
|
4.24M |
|
4.24M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$9.27M |
|
$0.34M |
|
$1.85M |
|
$11.12M |
|
$4.87M |
|
-- |
|
$2.91M |
|
$7.78M |
|
$2.81M |
|
$3.34M |
|
$3.34M |
|
4.24M |
|
| Cash Flow Statement Financials | |
$-4.85M |
|
$-0.00M |
|
-- |
|
$13.20M |
|
$8.35M |
|
$-4.85M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.90 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-200.90% |
|
-169.53% |
|
-50.85% |
|
-169.53% |
|
$0.79 |
|
$-1.14 |
|
$-1.14 |
|